FIELD: medicine.
SUBSTANCE: blood serum TNF-α is determined. The absence of the TNF-α concentrations to be determined, activity or a risk of aggravation of uveitis is predicted, while TNF-α to 21 pcg/ml shows ensured and/or maintained remission of the inflammatory process.
EFFECT: method enables correcting the therapy accompanying immunological monitoring, avoiding undue prescription of the drug preparation, promotes more effective therapy of uveitis, prevents developing complications.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS | 2005 |
|
RU2298188C1 |
| WAY OF FORECASTING OF ADVANCE OF PROLIFERATIVE COMPLICATIONS AT PERIPHERIC UVEITES AT CHILDREN | 2008 |
|
RU2362172C1 |
| METHOD FOR PREDICTION OF DEVELOPING OR PROGRESSING PROLIFERATIVE SYNDROME IN ENDOGENOUS UVEITIS IN CHILDREN | 2015 |
|
RU2584246C1 |
| METHOD FOR PREDICTING UVEITIS DEVELOPMENT COURSE IN THE CASES OF SYSTEMIC OR SYNDROMIC DISEASES | 1999 |
|
RU2157541C1 |
| METHOD FOR PREDICTING ENDOGENOUS UVEITIS DEVELOPMENT COURSE IN CHILDREN | 2001 |
|
RU2199123C1 |
| METHOD FOR PREDICTION OF ORGAN-SPECIFIC SELF-IMMUNISATION IN INFLAMMATORY EYE DISORDERS | 2014 |
|
RU2564929C1 |
| PROGNOSIS METHOD OF UVEITIS DEVELOPMENT IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS | 2016 |
|
RU2613056C1 |
| METHOD FOR PREDICTING EXACERBATION OF CHRONIC UVEITIS IN MEN WITH ANKYLOSING SPONDYLITIS | 2022 |
|
RU2782116C1 |
| METHOD FOR DETERMINING INDICATIONS FOR ACTIVE ANTI-INFLAMMATORY THERAPY BEFORE PERFORMING OPTO-RECONSTRUCTIVE OPERATIONS IN CHILDREN WITH ENDOGENOUS UVEITIS | 2022 |
|
RU2782132C1 |
| METHOD FOR PREDICTING HIGH RISK OF AUTOIMMUNE INFLAMMATION IN POST-TRAUMATIC UVEITIS IN LONG TERM | 2021 |
|
RU2754292C1 |
